These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3005653)

  • 21. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome.
    Tsai CS; Ritch R; Straus SE; Perry HD; Hsieh FY
    Arch Ophthalmol; 1990 Nov; 108(11):1572-6. PubMed ID: 2173898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.
    Thorley-Lawson DA; Israelsohn ES
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5384-8. PubMed ID: 3037547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr (EB) virus antibodies in rheumatoid arthritis.
    Ferrell PB; Tan EM
    Springer Semin Immunopathol; 1981; 4(2):181-91. PubMed ID: 6275562
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virus.
    Szigeti R; Masucci MG; Masucci G; Aman P; Klein G; Klein E
    Immunol Lett; 1985; 9(5):267-73. PubMed ID: 2987111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infections.
    Olson GB; Kanaan MN; Kelley LM; Jones JF
    J Allergy Clin Immunol; 1986 Aug; 78(2):315-20. PubMed ID: 3016067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First international symposium on Epstein-Barr virus and associated malignant diseases.
    Ablashi DV; Levine PH; Papas T; Pearson GR; Kottaridis SD
    Cancer Res; 1985 Aug; 45(8):3981-4. PubMed ID: 2990679
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
    Rowe M; Hildreth JE; Rickinson AB; Epstein MA
    Int J Cancer; 1982 Apr; 29(4):373-81. PubMed ID: 6282762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new manifestation of infection with Epstein-Barr virus.
    Smith H; Denman AM
    Br Med J; 1978 Jul; 2(6132):248. PubMed ID: 209846
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune surveillance against Epstein-Barr virus.
    Moss DJ; Burrows SR; Khanna R; Misko IS; Sculley TB
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
    Katsuki T; Katsuki K; Imai J; Hinuma Y
    Jpn J Cancer Res; 1987 Jul; 78(7):639-42. PubMed ID: 3040648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr herpesvirus infection: inhibition by immunologically induced mediators with interferon-like properties.
    Lai PK; Alpers MP; MacKay-Scollay EM
    Int J Cancer; 1977 Jul; 20(1):21-9. PubMed ID: 198380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins.
    Welinder C; Larsson NG; Szigeti R; Ehlin-Henriksson B; Henle G; Henle W; Klein G; Ricksten A; Rymo L; Sulitzeanu D
    Int J Cancer; 1987 Sep; 40(3):389-95. PubMed ID: 3040603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro evaluation of cell-mediated immunity to Epstein-Barr herpesvirus by cell migration inhibition tests.
    Lai PK; Alpers MP; Mackay Scollay EM
    J Natl Cancer Inst; 1975 Dec; 55(6):1319-22. PubMed ID: 173867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes.
    Petti L; Kieff E
    J Virol; 1988 Jun; 62(6):2173-8. PubMed ID: 2835517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell memory: lessons from Epstein-Barr virus infection in man.
    Rickinson AB; Callan MF; Annels NE
    Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):391-400. PubMed ID: 10794060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.